These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 27534746)

  • 1. Major methylation alterations on the CpG markers of inflammatory immune associated genes after IVIG treatment in Kawasaki disease.
    Li SC; Chan WC; Huang YH; Guo MM; Yu HR; Huang FC; Kuo HC; Kuo HC
    BMC Med Genomics; 2016 Aug; 9 Suppl 1(Suppl 1):37. PubMed ID: 27534746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying genetic hypomethylation and upregulation of Toll-like receptors in Kawasaki disease.
    Huang YH; Li SC; Huang LH; Chen PC; Lin YY; Lin CC; Kuo HC
    Oncotarget; 2017 Feb; 8(7):11249-11258. PubMed ID: 28061462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FCGR2A Promoter Methylation and Risks for Intravenous Immunoglobulin Treatment Responses in Kawasaki Disease.
    Kuo HC; Hsu YW; Wu MS; Woon PY; Wong HS; Tsai LJ; Lin RK; Klahan S; Hsieh KS; Chang WC
    Mediators Inflamm; 2015; 2015():564625. PubMed ID: 26089602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiomics analyses identified epigenetic modulation of the S100A gene family in Kawasaki disease and their significant involvement in neutrophil transendothelial migration.
    Huang LH; Kuo HC; Pan CT; Lin YS; Huang YH; Li SC
    Clin Epigenetics; 2018 Nov; 10(1):135. PubMed ID: 30382880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of an association between genomic hypomethylation of FCGR2A and susceptibility to Kawasaki disease and intravenous immunoglobulin resistance by DNA methylation array.
    Kuo HC; Chang JC; Kuo HC; Yu HR; Wang CL; Lee CP; Huang LT; Yang KD
    Arthritis Rheumatol; 2015 Mar; 67(3):828-36. PubMed ID: 25470559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HAMP promoter hypomethylation and increased hepcidin levels as biomarkers for Kawasaki disease.
    Huang YH; Kuo HC; Li SC; Cai XY; Liu SF; Kuo HC
    J Mol Cell Cardiol; 2018 Apr; 117():82-87. PubMed ID: 29501389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of increased expression of activating Fc receptors and novel findings regarding distinct IgE and IgM receptors in Kawasaki disease.
    Chang LS; Ming-Huey Guo M; Lo MH; Kuo HC
    Pediatr Res; 2021 Jan; 89(1):191-197. PubMed ID: 31816620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between T-cell HLA-DR expression and intravenous immunoglobulin treatment response in Kawasaki disease.
    Wakiguchi H; Hasegawa S; Suzuki Y; Kudo K; Ichiyama T
    Pediatr Res; 2015 Apr; 77(4):536-40. PubMed ID: 25580740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FCN1 (M-ficolin), which directly associates with immunoglobulin G1, is a molecular target of intravenous immunoglobulin therapy for Kawasaki disease.
    Okuzaki D; Ota K; Takatsuki SI; Akiyoshi Y; Naoi K; Yabuta N; Saji T; Nojima H
    Sci Rep; 2017 Sep; 7(1):11334. PubMed ID: 28900133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the genes associated with the response to intravenous immunoglobulin in patients with Kawasaki disease using DNA microarray analysis.
    Xing Y; Wang H; Liu X; Yu X; Chen R; Wang C; Yu X; Sun L
    Exp Mol Pathol; 2015 Feb; 98(1):7-12. PubMed ID: 25449331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NLRC4 methylation and its response to intravenous immunoglobulin therapy in Kawasaki disease: a case control study.
    Yu B; Zheng B; Shen Y; Shen Y; Qiu H; Wu L; Chen Y; Cai X; Wu J; Hong Q
    BMC Pediatr; 2024 Mar; 24(1):190. PubMed ID: 38493129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Th17- and Treg-related cytokine and mRNA expression are associated with acute and resolving Kawasaki disease.
    Guo MM; Tseng WN; Ko CH; Pan HM; Hsieh KS; Kuo HC
    Allergy; 2015 Mar; 70(3):310-8. PubMed ID: 25585854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the relationship between pyroptosis, infiltrating immune cells and Kawasaki disease with resistance to intravenous immunoglobulin (IVIG) via bioinformatic analysis.
    Xie Y; Han B
    Immunobiology; 2022 Sep; 227(5):152261. PubMed ID: 36029669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose intravenous immunoglobulin downregulates the activated levels of inflammatory indices except erythrocyte sedimentation rate in acute stage of Kawasaki Disease.
    Lee KY; Lee HS; Hong JH; Han JW; Lee JS; Whang KT
    J Trop Pediatr; 2005 Apr; 51(2):98-101. PubMed ID: 15677370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular and immunological biomarkers to predict IVIg response.
    Galeotti C; Kaveri SV; Bayry J
    Trends Mol Med; 2015 Mar; 21(3):145-7. PubMed ID: 25680699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional regulation by infliximab therapy in Kawasaki disease patients with immunoglobulin resistance.
    Ogihara Y; Ogata S; Nomoto K; Ebato T; Sato K; Kokubo K; Kobayashi H; Ishii M
    Pediatr Res; 2014 Sep; 76(3):287-93. PubMed ID: 24964229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous immunoglobulin therapy induces neutrophil apoptosis in Kawasaki disease.
    Tsujimoto H; Takeshita S; Nakatani K; Kawamura Y; Tokutomi T; Sekine I
    Clin Immunol; 2002 May; 103(2):161-8. PubMed ID: 12027421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepcidin-Induced Iron Deficiency Is Related to Transient Anemia and Hypoferremia in Kawasaki Disease Patients.
    Huang YH; Kuo HC; Huang FC; Yu HR; Hsieh KS; Yang YL; Sheen JM; Li SC; Kuo HC
    Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27187366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The B cell superantigen-like interaction of intravenous immunoglobin (IVIG) with Fab fragments of V(H) 3-23 and 3-30/3-30.5 germline gene origin cloned from a patient with Kawasaki disease is enhanced after IVIG therapy.
    Leucht S; Uttenreuther-Fischer MM; Gaedicke G; Fischer P
    Clin Immunol; 2001 Apr; 99(1):18-29. PubMed ID: 11286538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increase expression of CD177 in Kawasaki disease.
    Huang YH; Lo MH; Cai XY; Liu SF; Kuo HC
    Pediatr Rheumatol Online J; 2019 Apr; 17(1):13. PubMed ID: 30943984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.